153 related articles for article (PubMed ID: 7567838)
1. [Tumor lysis syndrome in chronic lymphoid leukemia treated with chlorambucil and prednisone].
Alliot C; Claisse JF; Desablens B
Presse Med; 1995 Sep 2-9; 24(25):1178. PubMed ID: 7567838
[No Abstract] [Full Text] [Related]
2. Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
Kosseifi SG; Vyas B; Vyas H; Krishnaswamy G; Smith S
Tenn Med; 2009 Oct; 102(10):33-6. PubMed ID: 19899317
[No Abstract] [Full Text] [Related]
3. Chronic lymphocytic leukemia in the elderly population.
Rai KR
Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
[TBL] [Abstract][Full Text] [Related]
4. Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.
Moutouh-de Parseval LA; Weiss L; DeLap RJ; Knight RD; Zeldis JB
J Clin Oncol; 2007 Nov; 25(31):5047. PubMed ID: 17971612
[No Abstract] [Full Text] [Related]
5. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
6. [Pressure pain in the left epigastrium: blood picture provides diagnosis. Chronic lymphatic leukemia].
Stiefelhagen P
MMW Fortschr Med; 2003 Sep; 145(39):55-6. PubMed ID: 14649082
[No Abstract] [Full Text] [Related]
7. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
Frame JN; Dahut WL; Crowley S
N Engl J Med; 1992 Nov; 327(19):1396-7. PubMed ID: 1406856
[No Abstract] [Full Text] [Related]
9. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
10. Lysis pneumonopathy associated with the use of fludarabine phosphate.
Crowley JJ; Knight L; Charan N
West J Med; 1994 Dec; 161(6):597-9. PubMed ID: 7531920
[No Abstract] [Full Text] [Related]
11. Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.
Mulligan SP; Dean MG
Aust N Z J Med; 1994 Aug; 24(4):406-7. PubMed ID: 7980241
[No Abstract] [Full Text] [Related]
12. Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia.
Han T; Ezdinli EZ; Shimaoka K; Desai DV
Cancer; 1973 Mar; 31(3):502-8. PubMed ID: 4693581
[No Abstract] [Full Text] [Related]
13. Role of interferon alpha-2b, chlorambucil and prednisone in the treatment of chronic lymphocytic leukemia.
Molica S
Eur J Haematol; 1992 Feb; 48(2):117-8. PubMed ID: 1547874
[No Abstract] [Full Text] [Related]
14. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
Montalban C; Liaño F; Aguilera A
Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632
[TBL] [Abstract][Full Text] [Related]
15. Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL).
Mandelli F; Gastaldi R; Monarca B; Coluzzi S; De Rossi G
Eur J Haematol; 1991 Jan; 46(1):58-9. PubMed ID: 1988312
[No Abstract] [Full Text] [Related]
16. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
17. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.
Knauf WU; Lissichkov T; Aldaoud A; Liberati A; Loscertales J; Herbrecht R; Juliusson G; Postner G; Gercheva L; Goranov S; Becker M; Fricke HJ; Huguet F; Del Giudice I; Klein P; Tremmel L; Merkle K; Montillo M
J Clin Oncol; 2009 Sep; 27(26):4378-84. PubMed ID: 19652068
[TBL] [Abstract][Full Text] [Related]
18. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
Robak T; Blonski JZ; Kasznicki M; Góra-Tybor J; Dmoszyñska A; Skotñicki A
Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
[TBL] [Abstract][Full Text] [Related]
19. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
[TBL] [Abstract][Full Text] [Related]
20. Severe adverse skin reaction to chlorambucil in a patient with chronic lymphocytic leukemia.
Aydogdu I; Ozcan C; Harputluoglu M; Karincaoglu Y; Turhan O; Ozcanu A
Anticancer Drugs; 1997 Jun; 8(5):468-9. PubMed ID: 9215610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
